Cancer Research UK has appointed games and software development agency Guerilla Tea, to develop the charity's first mobile phone game, to accurately locate new genetic causes of cancer, thus boosting potential new cures. Based on the ...
Tags: Cancer Research, Guerilla Tea
Elekta, a Sweden-based medical technology company, has received CE Mark for its Clarity 4D Monitoring system. 4D monitoring offers continuous tracking of the prostate and imaging of the surrounding anatomy, including the bladder, rectum ...
Snapper Rock, a line of UV50+ swimwear for kids, will be presenting its popular collection including 55 new styles in over 20 new eye-catching prints at Miami's premiere swimwear exhibition, SwimShow. Cool and eye-catching designs combined ...
Inspired by the streets of New York City, PINCH NYC is the newest urban lifestyle brand to hit the fashion world. PINCH NYC is a mash-up of New York City's high-end and urban designs meant to empower individual attitude, fashion expression ...
Tags: Apparel, Urban Lifestyle Brand
Israeli Drug discovery company Compugen is developing a Predictive Structural Biology (PSB) infrastructure platform to identify the functional interaction sites of proteins, which are useful in the rational design of novel drugs. Intended ...
Switzerland-based Roche has introduced new Progastrin-releasing peptide (ProGRP) test, Elecsys ProGRP, for precise differentiation of small cell (SCLC) and non-small cell (NSCLC) lung cancer and diagnosis of early-stage SCLC. Used with ...
Tags: Lung Cancer, Peptide Test
Researchers have developed an intelligent surgical knife that can help doctors identify if a tissue being cut is of cancerous nature or not, in turn enabling an accurate surgery. The knife, created by London's Imperial College ...
Tags: UK Researchers, Surgical Knife
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
Israel-based Given Imaging has secured regulatory clearance in Japan for its PillCam COLON, a video capsule that can help in the diagnosis of colonic disease in patients who are unable or unwilling to undergo colonoscopy. Given Imaging ...
Tags: Given Imaging, Capsule
Luminex has received approvals from the US Food and Drug Administration (FDA) and EU authorities for the new version of xTAG CYP2D6 (Cytochrome P450 2D6) Kit. An IVD assay, the xTAG CYP2D6 Kit analyses a patient's CYP2D6 genotype from ...
The UK National Institute for Health and Care Excellence (NICE) has rejected Pfizer’s new chronic myeloid leukaemia (CML) drug, Bosulif (bosutinib). NICE chief executive Sir Andrew Dillon said there is evidence to suggest that ...
Tags: Cancer Drug, Medicine
The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (metastatic) non-small cell lung cancer (NSCLC). The approval also ...
Tags: FDA, Lung Cancer Therapy, Medicine
India’s Health ministry is planning to organize an inter-ministerial meeting to inspect that the current foreign direct investment (FDI) limit in the pharma industry is not at the cost of the public health goals. The Department of ...
Boston Biomedical has relocated its headquarters to Cambridge, Massachusetts with the opening of a new 64,000ft2 facility, in a bid to advance its efforts in discovering next generation of targeted cancer therapeutics. Commenting on the ...
Tags: Boston, Cambridge, Biomedical
Astellas Pharma has announced the availability of Xtandi (enzalutamide), a new treatment for advanced prostate cancer in patients who have failed on first-line hormonal treatments and docetaxel chemotherapy, in the UK. Administered ...
Tags: Astellas, Cancer Medication